BEIJING, Jan. 12 (Xinhua) — Starting from May, diabetes patients in China will enjoy an average 48 percent drop in their medicine costs. The price cut will be effective on about 40 commonly used insulin products selected by the country’s centralized drug procurement program in November.

Chinese diabetics to enjoy favorable drug prices from May – comes via ChinaTechNews.com.